Aragen Life Sciences secured a $100 million investment from Quadria Capital, selling a 10% stake at a $1.4 billion valuation.

Unlike first-generation entrepreneurs, Parvinder inherited Ranbaxy—a modest pharma business his father, Bhai Mohan Singh, had acquired from its founders, Ranbir Singh and Gurbax Singh. A wealthy ...

He has previously worked with Cadila Healthcare and Ranbaxy Laboratories, and is now the COO of Inventia Healthcare. Manjula Devi Shroff is a Non-Executive, Independent Director with over 15 years ...